Using e-Bug classroom education to boost HPV vaccine consent in a middle school
Pilot Observational Comparative Study Evaluating the Impact of the e-Bug Educational Programme on Parental Consent and HPV Vaccination Coverage During the National School-Based Vaccination Campaign in a Middle School in the Alpes-Maritimes
This project tests whether using the e-Bug classroom education in a French middle school helps increase parental consent and HPV vaccination rates among eligible students during the 2023–2025 school campaigns.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 11000 (estimated) |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire de Nice Academic / other |
| Locations | 1 site (Nice, Alpes Maritimes) |
| Trial ID | NCT07266857 on ClinicalTrials.gov |
What this trial studies
This is a non-interventional observational pilot using aggregated, anonymised vaccination data collected routinely by ARS PACA for the 2023–2024 and 2024–2025 national school-based HPV vaccination campaigns. The pilot school in the Alpes-Maritimes department had teachers and the school nurse already using e-Bug resources as part of routine health education; no new intervention was introduced or modified for research purposes. Aggregated vaccination consent and uptake from the pilot school are compared with departmental-level outcomes to describe whether upstream classroom education may be associated with differences in parental consent and vaccination coverage. No individual-level data or direct recruitment of students or families occurred for this analysis.
Who should consider this trial
Good fit: The analysis concerns aggregated data for middle school students eligible for routine school-based HPV vaccination (early adolescents) at the pilot school and in the Alpes-Maritimes department.
Not a fit: Students outside the routine vaccination age range, those already up-to-date with HPV vaccination, or students at schools that did not use e-Bug would not see direct benefit from this pilot's findings.
Why it matters
Potential benefit: If successful, this approach could increase parental consent and HPV vaccine uptake among middle school students, supporting broader school-based education as a tool to improve vaccination coverage.
How similar studies have performed: Previous school-based education and informational campaigns have sometimes increased parental consent or vaccine uptake, but results across studies have been mixed and often modest.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * No individual participants are enrolled. The study uses only aggregated, anonymised vaccination data routinely collected by ARS PACA Exclusion Criteria: * Not applicable. No individual-level inclusion or exclusion criteria are defined, as no participants are enrolled.
Where this trial is running
Nice, Alpes Maritimes
- CHU de NICE — Nice, Alpes Maritimes, France (Recruiting)
Study contacts
- Study coordinator: Laure Hermet
- Email: hermet.l@chu-nice.fr
- Phone: 0492039007
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.